# CSHL 2020 Conference on Neurodegenerative Diseases: Biology & Therapeutics

> **NIH NIH R13** · COLD SPRING HARBOR LABORATORY · 2020 · $29,680

## Abstract

ABSTRACT
This proposal seeks support for the biennial conference on Neurodegenerative Diseases: Biology &
Therapeutics, from December 2 – December 5, 2020 at Cold Spring Harbor Laboratory (CSHL). The meeting
brings together scientists who investigate both basic and translational aspects of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. For many of these
disorders, the molecular pathways of the disease processes remain unclear and thus few biomarkers have
been identified. For other disorders, existing treatments are designed primarily to provide relief from symptoms
without addressing the biology underlying degenerative processes. Translational research is therefore needed
to develop and validate novel diagnostic strategies as well as new therapeutics that might halt or stem disease
progression, rather than simply alleviate symptoms. The conference will advance knowledge in
neurodegeneration by providing a forum where scientists from distinct laboratories and institutions, both
academic and industry, can exchange findings, ideas, and seek collaborations. It will include sessions on
propagation mechanisms of neurodegenerative diseases, network mechanisms of neurodegeneration,
neuroinflammation and glial biology of neurodegeneration, APOE and lipid metabolism, RNA metabolism in
neurodegeneration, and endolysosome, autophagy, and other targets in therapeutics. For human studies
seeking new treatments for neurodegeneration to be informative, it is essential for scientists who research
different aspects of those treatments to meet regularly in a setting like CSHL to exchange data and ideas. The
2020 CSHL meeting on Neurodegenerative Diseases: Biology & Therapeutics will build on the successes of
prior CSHL meetings to assemble an international gathering of top scientists, discuss new developments in the
field, and catalyze innovative research collaborations, all of which will ultimately accelerate the pace of
discovery.

## Key facts

- **NIH application ID:** 10070681
- **Project number:** 1R13AG069514-01
- **Recipient organization:** COLD SPRING HARBOR LABORATORY
- **Principal Investigator:** DAVID J. STEWART
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $29,680
- **Award type:** 1
- **Project period:** 2020-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10070681

## Citation

> US National Institutes of Health, RePORTER application 10070681, CSHL 2020 Conference on Neurodegenerative Diseases: Biology & Therapeutics (1R13AG069514-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10070681. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*